Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × orelabrutinib × Clear all

Phase

Phase 2 6 Phase 3 1 Phase 1/2 1

Status

Recruiting 4 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cisplatin 120 Radiotherapy 88 Carboplatin 75 Paclitaxel 71 Cyclophosphamide 71 Fluorouracil 68 Gemcitabine 62 Docetaxel 61 Capecitabine 60 Oxaliplatin 55 Etoposide 54 Doxorubicin 53 Vincristine 43 Leucovorin 39 Cytarabine 35 Chemotherapy, Adjuvant 35 Drug Therapy 30 Dexamethasone 30 Pemetrexed 25 Epirubicin 25 Bevacizumab 24 Prednisone 22 Tamoxifen 21 Neoadjuvant Therapy 21 Irinotecan 21 Methotrexate 19 Rituximab 18 Radiotherapy, Intensity-Modulated 18 Melphalan 18 apatinib 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05234684 2024-02-07

BELIEVE-01

Beijing InnoCare Pharma Tech Co., Ltd.

Phase 3 Unknown

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡